Ethics and Drug Resistance: Collective Responsibility for Global Public Health
| dc.contributor.editor | Jamrozik, Euzebiusz | |
| dc.contributor.editor | Selgelid, Michael | |
| dc.date.accessioned | 2025-03-08T06:45:33Z | |
| dc.date.available | 2025-03-08T06:45:33Z | |
| dc.date.issued | 2020 | |
| dc.date.submitted | 2020-11-13T13:34:54Z | |
| dc.identifier | ONIX_20201113_9783030278748_19 | |
| dc.identifier | https://library.oapen.org/handle/20.500.12657/42913 | |
| dc.identifier.uri | https://doab-dev.siscern.org/handle/20.500.12854/185365 | |
| dc.description.abstract | This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century. | |
| dc.language | English | |
| dc.relation.ispartofseries | Public Health Ethics Analysis | |
| dc.rights | open access | |
| dc.subject.other | Bioethics | |
| dc.subject.other | Drug Resistance | |
| dc.subject.other | Infectious Diseases | |
| dc.subject.other | Moral Philosophy and Applied Ethics | |
| dc.subject.other | Medical Microbiology | |
| dc.subject.other | Internal Medicine | |
| dc.subject.other | antimicrobial resistance | |
| dc.subject.other | public health ethics | |
| dc.subject.other | collective responsibility | |
| dc.subject.other | infectious disease | |
| dc.subject.other | global health | |
| dc.subject.other | hospital acquired infection | |
| dc.subject.other | animal ethics | |
| dc.subject.other | animal epidemiology | |
| dc.subject.other | TB resistance and human rights | |
| dc.subject.other | TB resistance in developing countries | |
| dc.subject.other | privacy and data collection | |
| dc.subject.other | ethics and AMR regulation | |
| dc.subject.other | ethics of drug development | |
| dc.subject.other | Pharmacology | |
| dc.subject.other | Infectious & contagious diseases | |
| dc.subject.other | thema EDItEUR::P Mathematics and Science::PS Biology, life sciences::PSA Life sciences: general issues::PSAD Bioethics | |
| dc.subject.other | thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology | |
| dc.subject.other | thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCJ Infectious and contagious diseases | |
| dc.title | Ethics and Drug Resistance: Collective Responsibility for Global Public Health | |
| dc.type | book | |
| oapen.identifier.doi | 10.1007/978-3-030-27874-8 | |
| oapen.relation.isPublishedBy | 9fa3421d-f917-4153-b9ab-fc337c396b5a | |
| oapen.relation.hasChapter | f2415d7b-ca4f-4ad6-a6eb-068696ebb965 | |
| oapen.imprint | Springer International Publishing | |
| oapen.pages | 448 | |
| dc.seriesnumber | 5 |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||
Ce document figure dans la(les) collection(s) suivante(s)
Chapters in this book
-
(2020)Restrictive policies that limit antimicrobial consumption, including therapeutically justified use, might be necessary to tackle the problem of antimicrobial resistance. We argue that such policies would be ethically ...

